Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4
Open Access
- 29 August 2016
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 36 (7) , 912-921
Abstract
Fatty acid binding protein 4 (FABP4) is a fatty acid chaperone, which is induced during adipocyte differentiation. Previously we have shown that FABP4 in endothelial cells is induced by the NOTCH1 signalling pathway, the latter of which is involved in mechanisms of resistance to antiangiogenic tumour therapy. Here, we investigated the role of FABP4 in endothelial fatty acid metabolism and tumour angiogenesis. We analysed the effect of transient FABP4 knockdown in human umbilical vein endothelial cells on fatty acid metabolism, viability and angiogenesis. Through therapeutic delivery of siRNA targeting mouse FABP4, we investigated the effect of endothelial FABP4 knockdown on tumour growth and blood vessel formation. In vitro, siRNA-mediated FABP4 knockdown in endothelial cells led to a marked increase of endothelial fatty acid oxidation, an increase of reactive oxygen species and decreased angiogenesis. In vivo, we found that increased NOTCH1 signalling in tumour xenografts led to increased expression of endothelial FABP4 that decreased when NOTCH1 and VEGFA inhibitors were used in combination. Angiogenesis, growth and metastasis in ovarian tumour xenografts were markedly inhibited by therapeutic siRNA delivery targeting mouse endothelial FABP4. Therapeutic targeting of endothelial FABP4 by siRNA in vivo has antiangiogenic and antitumour effects with minimal toxicity and should be investigated further.Keywords
This publication has 32 references indexed in Scilit:
- A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of AngiogenesisCancer Cell, 2013
- Gamma secretase inhibitors of Notch signalingOncoTargets and Therapy, 2013
- A Novel Cutaneous Fatty Acid-Binding Protein-Related Signaling Pathway Leading to Malignant Progression in Prostate Cancer CellsGenes & Cancer, 2013
- Fatty acid binding protein 4 is expressed in distinct endothelial and non‐endothelial cell populations in glioblastomaNeuropathology and Applied Neurobiology, 2012
- Biological Roles of the Delta Family Notch Ligand Dll4 in Tumor and Endothelial Cells in Ovarian CancerCancer Research, 2011
- Molecular control of endothelial cell behaviour during blood vessel morphogenesisNature Reviews Molecular Cell Biology, 2011
- Statistical Inference for Tumor Growth Inhibition T/C RatioJournal of Biopharmaceutical Statistics, 2010
- Regulation of Tumor Angiogenesis by EZH2Cancer Cell, 2010
- Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cellsThe FASEB Journal, 2009
- Gene Alterations Identified by Expression Profiling in Tumor-Associated Endothelial Cells from Invasive Ovarian CarcinomaCancer Research, 2007